Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer: A Systematic Diagnostic Attempt-Reference-Cited by-同舟云学术

Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer: A Systematic Diagnostic Attempt

Published:2012-09 Issue:3 Volume:10 Page:164-173
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Matei Deliu-Victor,Renne Giuseppe,Pimentel Marcelo,Sandri Maria Teresa,Zorzino Laura,Botteri Edoardo,De Cicco Concetta,Musi Gennaro,Brescia Antonio,Mazzoleni Federica,Tringali Valeria,Detti Serena,de Cobelli Ottavio

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference52 articles.

1. Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?;Sciarra;BJU Int,2003

2. Neuroendocrine differentiation in the progression of prostate cancer;Komiya;Int J Urol,2009

3. Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities;Vashchenko;Eur Urol,2005

4. Neuroendocrine differentiation in prostatic carcinoma;Abrahamsson;Prostate,1999

5. Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies;Casella;J Urol,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkers;Cancer Treatment Reviews;2024-04

2. Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer;Journal of Cancer Research and Clinical Oncology;2023-03-13

3. Chromogranin A: a useful biomarker in castration-resistant prostate cancer;World Journal of Urology;2022-12-17

4. SSTR-based theranostics in neuroendocrine prostate cancer (NEPC);Clinical and Translational Imaging;2022-12-12

5. Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer: Results from a multicenter radical prostatectomy cohort;The Prostate;2022-08-03